Dexcom implements GenAI into glucose biosensor devices
The applications of generative artificial intelligence (GenAI) have reached continuous glucose monitoring after DexCom launched rolled out the technology into…
The applications of generative artificial intelligence (GenAI) have reached continuous glucose monitoring after DexCom launched rolled out the technology into…
Diabetes patients in the US will have greater flexibility in managing insulin delivery after Insulet announced its Omnipod pump is…
Medtronic has received clearance from the US Food and Drug Administration (FDA) for its new InPen app, paving the way…
Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim…
ReShape Lifesciences has received a $241,000 grant from the US National Institutes of Health (NIH) to develop electrodes for its…
Insulet has launched the Omnipod 5 automated insulin delivery app for iPhone in the US. The app obviates the need…
US-based device company Luna Diabetes has initiated a pivotal trial evaluating its automated closed-loop insulin technology, the Luna System, in…
The US Food and Drug Administration (FDA) has issued a Class I tag to Medtronic’s recall of its MiniMed insulin…
Tandem Diabetes Care has announced that its t:slim X2 insulin pump, featuring Control-IQ automated insulin delivery technology, received approval for…
Medical technology companies Senseonics and Ascensia Diabetes Care have announced receipt of the US Food and Drug Administration (FDA) approval…